I would add that 90% controlled by key institutional funds working collaboratively to prevent market mishaps/manipulation. It's a bigger factor than most think. pjns316 has this thing analyzed pretty well imho.
Couldn't have said it better myself. I hear that second submission of a drug for FDA approval has close to a 75% chance of success. I am in for 78k shares because al tho the risk is evident, the upside potential is much larger.